Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hereditary hyperekplexia in which the cause of the disease is a mutation in the GLRB gene.
Features include always present findings: Hypertonia, Hiatus hernia, Exaggerated startle response, and Increased fetal movement and others; and common findings: Esotropia. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Exaggerated startle response, Intellectual disability, Sudden, brief involuntary muscle jerks (myoclonus) |
GLRB encodes glycine receptor beta (497 aa). Subunit of heteromeric glycine-gated chloride channels. Plays an important role in the down-regulation of neuronal excitability. Contributes to the generation of inhibitory postsynaptic currents Highest expression in Brain Frontal Cortex BA9 (52.8 TPM) and Brain Cerebellar Hemisphere (35.1 TPM).
Hyperekplexia 2 is associated with mutations in the GLRB gene on chromosome 4.
The GLRB protein participates in GLRA:GLRB:Gly transports extracellular Cl- to cytosol pathway.
GLRB is classified as a druggable target (Druggable Genome and Ion Channel categories) with score 5.2.
Genetic testing for GLRB is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 1 common feature.
No clinical trials have been registered for hyperekplexia 2.
19 publications have been identified in PubMed for hyperekplexia 2. Research spans Case Report / Case Series (74%), Review / Meta-Analysis (11%), and Other (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 74% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Pregnancy and birth |
1 |
Increased fetal movement |
Muscles | 1 | Muscle stiffness |
Digestive system | 1 | Gastroesophageal reflux |
Age of onset: before birth, at birth.
2 |
11% |
Other research | 1 | 5% |
Clinical study results | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Sarigecili E (2026). [PMID: 42013565](https://pubmed.ncbi.nlm.nih.gov/42013565/). *Pediatr Neurol*. [Review / Meta-Analysis]
Lin SZ (2026). [PMID: 41578547](https://pubmed.ncbi.nlm.nih.gov/41578547/). *Medicine*. [Other]
Qin L (2025). [PMID: 40308612](https://pubmed.ncbi.nlm.nih.gov/40308612/). *Frontiers in immunology*. [Case Report / Case Series]
Boeykens F (2025). [PMID: 40012122](https://pubmed.ncbi.nlm.nih.gov/40012122/). *Animal genetics*. [Case Report / Case Series]
Pina D (2025). [PMID: 40192101](https://pubmed.ncbi.nlm.nih.gov/40192101/). *Movement disorders clinical practice*. [Case Report / Case Series]
Santos BSCD (2025). [PMID: 40136121](https://pubmed.ncbi.nlm.nih.gov/40136121/). *Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo*. [Case Report / Case Series]
Özgün N (2025). [PMID: 39896699](https://pubmed.ncbi.nlm.nih.gov/39896699/). *Iranian journal of child neurology*. [Clinical Trial Publication]
Yılmaz FH (2025). [PMID: 41064056](https://pubmed.ncbi.nlm.nih.gov/41064056/). *Molecular syndromology*. [Case Report / Case Series]
Li EC (2025). [PMID: 39693598](https://pubmed.ncbi.nlm.nih.gov/39693598/). *Neurology(R) neuroimmunology & neuroinflammation*. [Case Report / Case Series]
Soliman Y (2025). [PMID: 39753277](https://pubmed.ncbi.nlm.nih.gov/39753277/). *BMJ case reports*. [Case Report / Case Series]